Get the Stockscreener App
3.25
3.85%
-0.13
Sonnet Biotherapeutics Holdings Inc stock is traded at $3.25, with a volume of 336.41K.
It is down -3.85% in the last 24 hours and down -0.31% over the past month.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$3.38
Open:
$3.29
24h Volume:
336.41K
Relative Volume:
0.09
Market Cap:
$21.95M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
-0.2904
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
-6.34%
1M Performance:
-0.31%
6M Performance:
+111.04%
1Y Performance:
-42.78%
1-Day Range:
$3.16
$3.44
1-Week Range:
$3.16
$3.90
52-Week Range:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Name
Sonnet Biotherapeutics Holdings Inc
Sector
Industry
Phone
609-375-2227
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
3.25 | 22.83M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News
Detecting support and resistance levels for Sonnet BioTherapeutics Holdings Inc.Trend Reversal & Daily Technical Forecast Reports - Newser
Is Sonnet BioTherapeutics Holdings Inc. forming a bottoming baseJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Using data filters to optimize entry into Artiva Biotherapeutics Inc.Portfolio Value Summary & Stepwise Swing Trade Plans - Newser
Has Sonnet BioTherapeutics Holdings Inc. formed a bullish divergenceRecession Risk & Daily Profit Maximizing Tips - Newser
Analyzing drawdowns of Sonnet BioTherapeutics Holdings Inc. with statistical toolsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - Newser
Is Sonnet BioTherapeutics Holdings Inc. building a consolidation baseQuarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
What MACD and RSI say about Sonnet BioTherapeutics Holdings Inc.Recession Risk & Target Return Focused Picks - Newser
Understanding Sonnet BioTherapeutics Holdings Inc.’s price movement2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Technical signs of recovery in Sonnet BioTherapeutics Holdings Inc.2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - Newser
Using Ichimoku Cloud for Navigator Holdings Ltd. technicalsIndex Update & Fast Entry High Yield Stock Tips - Newser
Is Sonnet BioTherapeutics Holdings Inc. a candidate for recovery playWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
Risk vs reward if holding onto Sonnet BioTherapeutics Holdings Inc.Weekly Stock Report & Real-Time Sentiment Analysis - Newser
Should you wait for a breakout in Sonnet BioTherapeutics Holdings Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser
What MACD signals say about Sonnet BioTherapeutics Holdings Inc.2025 Stock Rankings & Expert Curated Trade Ideas - Newser
Will Sonnet BioTherapeutics Holdings Inc. Recover After Recent Decline2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - sundaytimes.kr
Published on: 2025-08-28 13:31:22 - Newser
Sonnet BioTherapeutics Holdings Inc. stock prediction for this weekSwing Trade & Safe Entry Point Alerts - Newser
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attention2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
How to escape a deep drawdown in Sonnet BioTherapeutics Holdings Inc.Analyst Upgrade & Free Real-Time Market Sentiment Alerts - Newser
Is Sonnet BioTherapeutics Holdings Inc. stock bottoming outJuly 2025 Fed Impact & Smart Investment Allocation Tips - Newser
What makes Sonnet BioTherapeutics Holdings Inc. stock attractive today2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - sundaytimes.kr
Real time breakdown of Sonnet BioTherapeutics Holdings Inc. stock performanceJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Analysts Spot Bullish Divergence in Sonnet BioTherapeutics Holdings Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Real time social sentiment graph for Sonnet BioTherapeutics Holdings Inc.Weekly Trade Report & Capital Efficient Trading Techniques - Newser
Real time alert setup for Sonnet BioTherapeutics Holdings Inc. performanceJuly 2025 Levels & Risk Managed Investment Signals - Newser
Chartists Watching For Breakout in Sonnet BioTherapeutics Holdings Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):